Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Iveric Bio Inc (ISEE)

Iveric Bio Inc (ISEE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,538,556
  • Shares Outstanding, K 118,078
  • Annual Sales, $ 0 K
  • Annual Income, $ -114,520 K
  • 60-Month Beta 1.51
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.49
Trade ISEE with:

Options Overview Details

View History
  • Implied Volatility 268.85% ( +0.17%)
  • Historical Volatility 58.20%
  • IV Percentile 99%
  • IV Rank 95.03%
  • IV High 280.10% on 09/02/21
  • IV Low 53.71% on 04/11/22
  • Put/Call Vol Ratio 4.33
  • Today's Volume 1,072
  • Volume Avg (30-Day) 5,399
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 132,556
  • Open Int (30-Day) 81,321

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.40
  • Number of Estimates 7
  • High Estimate -0.28
  • Low Estimate -0.50
  • Prior Year -0.23
  • Growth Rate Est. (year over year) -73.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.33 +30.49%
on 07/27/22
14.18 -4.90%
on 08/11/22
+1.73 (+14.72%)
since 07/12/22
3-Month
8.85 +52.32%
on 06/13/22
14.18 -4.90%
on 08/11/22
+3.54 (+35.61%)
since 05/12/22
52-Week
8.37 +61.05%
on 09/09/21
19.34 -30.32%
on 04/05/22
+3.99 (+42.04%)
since 08/12/21

Most Recent Stories

More News
Iveric Bio to Participate in the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference

IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Pravin U. Dugel, M.D., President, will participate in a panel discussion titled, “Differentiation in Emerging Treatments for GA dAMD -- Perspectives...

ISEE : 13.48 (+3.45%)
Iveric Bio to Present at the Wedbush PacGrow Healthcare Conference 2022

IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Glenn P. Sblendorio, Chief Executive Officer, and Keith Westby, Chief Operating Officer, will participate in a fireside chat at the Wedbush PacGrow...

ISEE : 13.48 (+3.45%)
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

IVERIC bio, Inc. (NASDAQ: ISEE) today reported that on August 1, 2022, the Company granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to two newly-hired, non-executive...

ISEE : 13.48 (+3.45%)
IVERIC bio, Inc. (ISEE) Q2 2022 Earnings Call Transcript

ISEE earnings call for the period ending June 30, 2022.

ISEE : 13.48 (+3.45%)
Iveric Bio Reports Second Quarter 2022 Operational Highlights and Financial Results

IVERIC bio, Inc. (Nasdaq: ISEE) today announced financial and operating results for the second quarter ended June 30, 2022 and provided a general business update.

ISEE : 13.48 (+3.45%)
Iveric Bio Announces Agreement for Up to $250 Million in Non-Dilutive Debt Financing with Hercules Capital and Silicon Valley Bank

IVERIC bio, Inc. (Nasdaq: ISEE) announced today that it has entered into a term loan debt financing facility with Hercules Capital, Inc. (NYSE: HTGC) and Silicon Valley Bank providing the Company with...

ISEE : 13.48 (+3.45%)
HTGC : 15.79 (+1.81%)
Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022

IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its second quarter 2022 financial and operating results on Tuesday, July 26, 2022. Following the announcement, the Iveric Bio management...

ISEE : 13.48 (+3.45%)
Iveric Bio Announces Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® at American Society of Retina Specialists Meeting

IVERIC bio, Inc. (Nasdaq: ISEE) announced today that in a post-hoc analysis from the GATHER1 clinical trial, Zimura showed a reduction of geographic atrophy lesion growth, compared to sham, across all...

ISEE : 13.48 (+3.45%)
Morgan Stanley: Despite Turbulent Economy, These Stocks Have Over 90% Upside Potential

Rising inflation has been the story of 2022, reaching roughly 8.5% in the latest report. To fight it, the Federal Reserve is raising interest rates and cutting back on the money supply – but that has...

ISEE : 13.48 (+3.45%)
XPOF : 19.30 (+18.48%)
DelSiTech and Iveric Bio Enter Exclusive Agreement for Development of Sustained Release Zimura®

/PRNewswire/ -- IVERIC bio, Inc. (Nasdaq: ISEE) and DelSiTech Ltd, announced today an exclusive global license agreement providing Iveric Bio with the right to...

ISEE : 13.48 (+3.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

IVERIC bio Inc. is a biotechnology company. It is focused on the discovery and development of novel gene therapy solutions to treat orphan inherited retinal diseases. IVERIC bio Inc., formerly known as Ophthotech Corporation, is based in New York, United States.

See More

Key Turning Points

3rd Resistance Point 14.43
2nd Resistance Point 14.09
1st Resistance Point 13.78
Last Price 13.48
1st Support Level 13.13
2nd Support Level 12.79
3rd Support Level 12.48

See More

52-Week High 19.34
Fibonacci 61.8% 15.15
Fibonacci 50% 13.86
Last Price 13.48
Fibonacci 38.2% 12.56
52-Week Low 8.37

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar